{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:12:00Z","timestamp":1792023120051,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chinese National Key Technology R&D Program","award":["Ministry of Science"],"award-info":[{"award-number":["Ministry of Science"]}]},{"name":"Chinese National Key Technology R&D Program","award":["Technology (2024YFC2510300)"],"award-info":[{"award-number":["Technology (2024YFC2510300)"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["(2021-I2M-1-005"],"award-info":[{"award-number":["(2021-I2M-1-005"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2022-I2M-1-004"],"award-info":[{"award-number":["2022-I2M-1-004"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-2-005)"],"award-info":[{"award-number":["2023-I2M-2-005)"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2025-PUMCH-D-001"],"award-info":[{"award-number":["2025-PUMCH-D-001"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013"],"award-info":[{"award-number":["2022-PUMCH-B-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10067-026-07994-3","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:57:39Z","timestamp":1772517459000},"page":"2703-2719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring clinical subtypes of Chinese patients with psoriatic arthritis based on cluster analysis: a national registry study (CREPAR\u00a0V)"],"prefix":"10.1007","volume":"45","author":[{"given":"Yaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0215-9176","authenticated-orcid":false,"given":"Xiaomei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"issue":"1","key":"7994_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS (2017) Psoriatic arthritis: state of the art review. Clin Med 17(1):65\u201370. https:\/\/doi.org\/10.7861\/clinmedicine.17-1-65","journal-title":"Clin Med"},{"issue":"1","key":"7994_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.medcli.2022.01.024","volume":"159","author":"A L\u00f3pez-Ferrer","year":"2022","unstructured":"L\u00f3pez-Ferrer A, Laiz A, Puig L (2022) Psoriatic arthritis. Med Clin (Barc) 159(1):40\u201346. https:\/\/doi.org\/10.1016\/j.medcli.2022.01.024","journal-title":"Med Clin (Barc)"},{"issue":"10136","key":"7994_CR3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","volume":"391","author":"DJ Veale","year":"2018","unstructured":"Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391(10136):2273\u20132284. https:\/\/doi.org\/10.1016\/S0140-6736(18)30830-4","journal-title":"Lancet"},{"key":"7994_CR4","doi-asserted-by":"publisher","unstructured":"Ocampo D V, Gladman D. Psoriatic arthritis. F1000Res. 2019 Sep 20;8:F1000 Faculty Rev-1665. https:\/\/doi.org\/10.12688\/f1000research.19144.1","DOI":"10.12688\/f1000research.19144.1"},{"issue":"2","key":"7994_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101670","volume":"35","author":"M Kishimoto","year":"2021","unstructured":"Kishimoto M, Deshpande GA, Fukuoka K, Kawakami T, Ikegaya N, Kawashima S, Komagata Y, Kaname S (2021) Clinical features of psoriatic arthritis. Best Pract Res Clin Rheumatol 35(2):101670. https:\/\/doi.org\/10.1016\/j.berh.2021.101670","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"7994_CR6","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s10067-021-05841-1","volume":"40","author":"AB Maharaj","year":"2021","unstructured":"Maharaj AB, Adebajo A (2021) Psoriatic arthritis in Africa. Clin Rheumatol 40(9):3411\u20133418. https:\/\/doi.org\/10.1007\/s10067-021-05841-1","journal-title":"Clin Rheumatol"},{"issue":"6","key":"7994_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-00999-8","volume":"23","author":"DD Gladman","year":"2021","unstructured":"Gladman DD (2021) Axial psoriatic arthritis. Curr Rheumatol Rep 23(6):35. https:\/\/doi.org\/10.1007\/s11926-021-00999-8","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"7994_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0771-z","volume":"20","author":"LR Espinoza","year":"2018","unstructured":"Espinoza LR (2018) The history of Psoriatic Arthritis (PsA): from moll and wright to pathway-specific therapy. Curr Rheumatol Rep 20(10):58. https:\/\/doi.org\/10.1007\/s11926-018-0771-z","journal-title":"Curr Rheumatol Rep"},{"issue":"Suppl 2(Suppl 2","key":"7994_CR9","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1136\/ard.2004.032318","volume":"64","author":"PS Helliwell","year":"2005","unstructured":"Helliwell PS, Taylor WJ (2005) Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 64(Suppl 2(Suppl 2)):ii3-8. https:\/\/doi.org\/10.1136\/ard.2004.032318","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7994_CR10","first-page":"172","volume":"38","author":"M Zlatkovic-Svenda","year":"2013","unstructured":"Zlatkovic-Svenda M, Kerimovic-Morina D, Stojanovic RM (2013) Psoriatic arthritis classification criteria: Moll and Wright, ESSG and CASPAR \u2013 a comparative study. Acta Reumatol Port 38(3):172\u20138","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"7994_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s100670170101","volume":"20","author":"T Ko\u00f3","year":"2001","unstructured":"Ko\u00f3 T, Nagy Z, Seszt\u00e1k M, Ujfalussy I, Mer\u00e9tey K, B\u00f6hm U, Forg\u00e1cs S, Szil\u00e1gyi M, Czirj\u00e1k L, Farkas V (2001) Subsets in psoriatic arthritis formed by cluster analysis. Clin Rheumatol 20(1):36\u201343. https:\/\/doi.org\/10.1007\/s100670170101","journal-title":"Clin Rheumatol"},{"issue":"3","key":"7994_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001728","volume":"7","author":"C L\u00f3pez-Medina","year":"2021","unstructured":"L\u00f3pez-Medina C, Chevret S, Molto A, Sieper J, Duru\u00f6z T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Biglia A, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Muntean L, van Gaalen FA, Geher P, Magrey M, Ib\u00e1\u00f1ez-Vodnizza SE, Bautista-Molano W, Maksymowych W, Machado PM, Landew\u00e9 R, van der Heijde D, Dougados M (2021) Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD Open 7(3):e001728. https:\/\/doi.org\/10.1136\/rmdopen-2021-001728","journal-title":"RMD Open"},{"issue":"11","key":"7994_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/acr.23189","volume":"69","author":"A Ibrahim","year":"2017","unstructured":"Ibrahim A, Gladman DD, Thavaneswaran A, Eder L, Helliwell P, Cook RJ, Chandran V (2017) Sensitivity and specificity of radiographic scoring instruments for detecting change in axial psoriatic arthritis. Arthritis Care Res (Hoboken) 69(11):1700\u20131705. https:\/\/doi.org\/10.1002\/acr.23189","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"7994_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ijd.17138","volume":"63","author":"H Rachadi","year":"2024","unstructured":"Rachadi H, Chiheb S (2024) Dermoscopic features of nail psoriasis: a systematic review. Int J Dermatol 63(8):1013\u20131019. https:\/\/doi.org\/10.1111\/ijd.17138","journal-title":"Int J Dermatol"},{"issue":"5","key":"7994_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.berh.2010.05.004","volume":"24","author":"LC Coates","year":"2010","unstructured":"Coates LC, Helliwell PS (2010) Disease measurement--enthesitis, skin, nails, spine and dactylitis. Best Pract Res Clin Rheumatol 24(5):659\u2013670. https:\/\/doi.org\/10.1016\/j.berh.2010.05.004","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"7994_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/rheumatology\/16.4.257","volume":"16","author":"PJ Scott","year":"1977","unstructured":"Scott PJ, Huskisson EC (1977) Measurement of functional capacity with visual analogue scales. Rheumatol Rehabil 16(4):257\u2013259. https:\/\/doi.org\/10.1093\/rheumatology\/16.4.257","journal-title":"Rheumatol Rehabil"},{"issue":"6","key":"7994_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/1756-185X.12695","volume":"18","author":"I Sengul","year":"2015","unstructured":"Sengul I, Akcay-Yalbuzdag S, Ince B, Goksel-Karatepe A, Kaya T (2015) Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis. Int J Rheum Dis 18(6):640\u2013645. https:\/\/doi.org\/10.1111\/1756-185X.12695","journal-title":"Int J Rheum Dis"},{"key":"7994_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152134","volume":"58","author":"EE Schneeberger","year":"2023","unstructured":"Schneeberger EE, Citera G, Nash P, Smolen JS, Mease PJ, Soriano ER, Helling C, Szumski AE, Mundayat R, de Le\u00f3n DP (2023) Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: a post hoc analysis of data from phase 3 tofacitinib studies. Semin Arthritis Rheum 58:152134. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152134","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"7994_CR19","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J (2011) Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken) 63(11):S47-58. https:\/\/doi.org\/10.1002\/acr.20575","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"7994_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59(5):686\u2013691. https:\/\/doi.org\/10.1002\/art.23568","journal-title":"Arthritis Rheum"},{"issue":"2","key":"7994_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/annrheumdis-2017-211998","volume":"77","author":"LJJ van Mens","year":"2018","unstructured":"van Mens LJJ, van de Sande MGH, van Kuijk AWR, Baeten D, Coates LC (2018) Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort. Ann Rheum Dis 77(2):251\u2013257. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211998","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"7994_CR22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3899\/jrheum.200556","volume":"48","author":"F Farkas","year":"2021","unstructured":"Farkas F, Ikumi N, Elmamoun M, Szentpetery A, FitzGerald O (2021) Comparison of composite measure remission targets in psoriatic arthritis. J Rheumatol 48(8):1272\u20131278. https:\/\/doi.org\/10.3899\/jrheum.200556","journal-title":"J Rheumatol"},{"key":"7994_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.acc.2023.03.006","volume":"115","author":"J Koussiouris","year":"2023","unstructured":"Koussiouris J, Chandran V (2023) Autoantibodies in psoriatic disease. Adv Clin Chem 115:135\u2013174. https:\/\/doi.org\/10.1016\/bs.acc.2023.03.006","journal-title":"Adv Clin Chem"},{"issue":"14","key":"7994_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411662","volume":"24","author":"BW Lee","year":"2023","unstructured":"Lee BW, Moon SJ (2023) Inflammatory cytokines in psoriatic arthritis: understanding pathogenesis and implications for treatment. Int J Mol Sci 24(14):11662. https:\/\/doi.org\/10.3390\/ijms241411662","journal-title":"Int J Mol Sci"},{"issue":"20","key":"7994_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010990","volume":"22","author":"MLM Mulder","year":"2021","unstructured":"Mulder MLM, He X, van den Reek JMPA, Urbano PCM, Kaffa C, Wang X, van Cranenbroek B, van Rijssen E, van den Hoogen FHJ, Joosten I, Alkema W, de Jong EMGJ, Smeets RL, Wenink MH, Koenen HJPM (2021) Blood-based immune profiling combined with machine learning discriminates psoriatic arthritis from psoriasis patients. Int J Mol Sci 22(20):10990. https:\/\/doi.org\/10.3390\/ijms222010990","journal-title":"Int J Mol Sci"},{"key":"7994_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1346757","volume":"11","author":"B Lob\u00e3o","year":"2024","unstructured":"Lob\u00e3o B, Louren\u00e7o D, Giga A, Mendes-Bastos P (2024) From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature. Front Med Lausanne 11:1346757. https:\/\/doi.org\/10.3389\/fmed.2024.1346757","journal-title":"Front Med Lausanne"},{"key":"7994_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320916014","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang SX, Hao YF, Qiu MT, Luo J, Li YY, Gao C, Li XF (2020) The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2. Ther Adv Chronic Dis 11:2040622320916014. https:\/\/doi.org\/10.1177\/2040622320916014","journal-title":"Ther Adv Chronic Dis"},{"key":"7994_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24924-w","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MAM, van Kempen T, Concepcion AN, van Laar JM, van Wijk F, Spierings J, Leijten EFA, Boes M (2022) Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161\u2009+\u2009ROR\u03b3t\u2009+\u2009ICOS\u2009+\u2009phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-24924-w","journal-title":"Sci Rep"},{"issue":"5","key":"7994_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/art.38376","volume":"66","author":"B Menon","year":"2014","unstructured":"Menon B, Gullick NJ, Walter GJ, Rajasekhar M, Garrood T, Evans HG, Taams LS, Kirkham BW (2014) Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression. Arthritis Rheumatol 66(5):1272\u20131281. https:\/\/doi.org\/10.1002\/art.38376","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"7994_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0198-8859(99)00034-8","volume":"60","author":"I Tassiulas","year":"1999","unstructured":"Tassiulas I, Duncan SR, Centola M, Theofilopoulos AN, Boumpas DT (1999) Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol 60(6):479\u2013491. https:\/\/doi.org\/10.1016\/s0198-8859(99)00034-8","journal-title":"Hum Immunol"},{"issue":"1","key":"7994_CR31","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","volume":"11","author":"F Penkava","year":"2020","unstructured":"Penkava F, Velasco-Herrera MDC, Young MD, Yager N, Nwosu LN, Pratt AG, Lara AL, Guzzo C, Maroof A, Mamanova L, Cole S, Efremova M, Simone D, Filer A, Brown CC, Croxford AL, Isaacs JD, Teichmann S, Bowness P, Behjati S, Hussein Al-Mossawi M (2020) Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis. Nat Commun 11(1):4767. https:\/\/doi.org\/10.1038\/s41467-020-18513-6","journal-title":"Nat Commun"},{"issue":"12","key":"7994_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115424","volume":"9","author":"M Dolcino","year":"2014","unstructured":"Dolcino M, Lunardi C, Ottria A, Tinazzi E, Patuzzo G, Puccetti A (2014) Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis. PLoS One 9(12):e115424. https:\/\/doi.org\/10.1371\/journal.pone.0115424","journal-title":"PLoS One"},{"issue":"1","key":"7994_CR33","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","volume":"59","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Coates LC, Gladman DD (2020) Treatment guidelines in psoriatic arthritis. Rheumatology (Oxford) 59(1):i37\u2013i46. https:\/\/doi.org\/10.1093\/rheumatology\/kez383","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"7994_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14060550","volume":"14","author":"KR Bonfiglioli","year":"2024","unstructured":"Bonfiglioli KR, Lopes FOA, Figueiredo LQ, Ferrari LFF, Guedes L (2024) Ultrasonographic insights into peripheral psoriatic arthritis: updates in diagnosis and monitoring. J Pers Med 14(6):550. https:\/\/doi.org\/10.3390\/jpm14060550","journal-title":"J Pers Med"},{"issue":"8","key":"7994_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","volume":"18","author":"LC Coates","year":"2022","unstructured":"Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, Chau J, Eder L, Fern\u00e1ndez-\u00c1vila DG, FitzGerald O, Garg A, Gladman DD, Goel N, Helliwell PS, Husni ME, Jadon DR, Katz A, Laheru D, Latella J, Leung YY, Lindsay C, Lubrano E, Mazzuoccolo LD, Mease PJ, O\u2019Sullivan D, Ogdie A, Olsder W, Palominos PE, Schick L, Steinkoenig I, de Wit M, van der Windt DA, Kavanaugh A, GRAPPA Treatment Recommendations domain subcommittees (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol 18(8):465\u2013479. https:\/\/doi.org\/10.1038\/s41584-022-00798-0","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"7994_CR36","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.semarthrit.2021.06.006","volume":"51","author":"D Poddubnyy","year":"2021","unstructured":"Poddubnyy D, Jadon DR, Van den Bosch F, Mease PJ, Gladman DD (2021) Axial involvement in psoriatic arthritis: an update for rheumatologists. Semin Arthritis Rheum 51(4):880\u2013887. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.006","journal-title":"Semin Arthritis Rheum"},{"key":"7994_CR37","doi-asserted-by":"publisher","first-page":"1505322","DOI":"10.3389\/fimmu.2024.1505322","volume":"15","author":"G Cafaro","year":"2025","unstructured":"Cafaro G, Bursi R, Valentini V, Hansel K, Perricone C, Venerito V, Bistoni O, Sebastiano M, Topini F, Stingeni L, Gerli R, Bartoloni E (2025) Combined semiquantitative nail-enthesis complex ultrasonography and capillaroscopy in psoriasis and psoriatic arthritis. Front Immunol 15:1505322. https:\/\/doi.org\/10.3389\/fimmu.2024.1505322","journal-title":"Front Immunol"},{"issue":"5","key":"7994_CR38","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10067-025-07395-y","volume":"44","author":"G Sakellariou","year":"2025","unstructured":"Sakellariou G, Girolimetto N, Tinazzi I, Canzoni M, Filippou G, Batticciotto A, Possemato N, Macchioni P, De Lucia O, Dejaco C, Idolazzi L, Pirri C, Iagnocco A (2025) The ultrasonographic spectrum of toe dactylitis in psoriatic arthritis: a descriptive analysis. Clin Rheumatol 44(5):1939\u20131947. https:\/\/doi.org\/10.1007\/s10067-025-07395-y","journal-title":"Clin Rheumatol"},{"key":"7994_CR39","doi-asserted-by":"publisher","unstructured":"Gossec L, Balanescu A, D'Agostino MA, Ogdie A, Sewerin P, Deng Y, Shi L, Sugimoto Y, Zhong S, Xing Y, Lippe R, Kishimoto M (2025) Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Na\u00efve patients in two phase 3 clinical trials. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-025-03670-0","DOI":"10.1186\/s13075-025-03670-0"},{"issue":"6","key":"7994_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40744-025-00793-3","volume":"12","author":"A \u00d6st\u00f6r","year":"2025","unstructured":"\u00d6st\u00f6r A, den Van Bosch F, Papp K, Keiserman M, Blanco R, Crowley A, White D, Biljan A, Madihlaba T, Carter K, Liu F, Soliman AM, Ashley D, Chen M, Glotfelty L, Kivitz A (2025) Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials. Rheumatol Ther 12(6):1103\u20131123. https:\/\/doi.org\/10.1007\/s40744-025-00793-3","journal-title":"Rheumatol Ther"},{"issue":"3","key":"7994_CR41","doi-asserted-by":"publisher","first-page":"e005522","DOI":"10.1136\/rmdopen-2025-005522","volume":"11","author":"LC Coates","year":"2025","unstructured":"Coates LC, Blanco R, Behrens F, Ogdie A, den Van Bosch F, Ranza R, Klionsky Y, Soliman AM, Chen M, Coombs D, Shi L, Urbanik JR, Iyile T, Lippe R, Gossec L (2025) Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. RMD Open 11(3):e005522. https:\/\/doi.org\/10.1136\/rmdopen-2025-005522","journal-title":"RMD Open"},{"key":"7994_CR42","doi-asserted-by":"publisher","first-page":"1294416","DOI":"10.3389\/fimmu.2023.1294416","volume":"14","author":"S Wu","year":"2023","unstructured":"Wu S, Xu Y, Yang L, Guo L, Jiang X (2023) Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Front Immunol 14:1294416. https:\/\/doi.org\/10.3389\/fimmu.2023.1294416","journal-title":"Front Immunol"},{"issue":"1","key":"7994_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jdv.12850","volume":"30","author":"C Phan","year":"2016","unstructured":"Phan C, Sigal ML, Est\u00e8ve E, Reguiai Z, Barth\u00e9l\u00e9my H, Beneton N, Maccari F, Lahfa M, Thomas-Beaulieu D, Le Guyadec T, Vermersch-Langlin A, Mery-Bossard L, Pallure V, Kemula M, Labeille B, Beauchet A, Mah\u00e9 E, GEM RESOPSO (2016) Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis. J Eur Acad Dermatol Venereol 30(1):78\u201382. https:\/\/doi.org\/10.1111\/jdv.12850","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9583","key":"7994_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370(9583):263\u2013271. https:\/\/doi.org\/10.1016\/S0140-6736(07)61128-3","journal-title":"Lancet"},{"issue":"1","key":"7994_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2310\/7750.2010.10013","volume":"15","author":"WP Gulliver","year":"2011","unstructured":"Gulliver WP, Macdonald D, Gladney N, Alaghehbandan R, Rahman P, Adam Baker K (2011) Long-term prognosis and comorbidities associated with psoriasis in the Newfoundland and Labrador founder population. J Cutan Med Surg 15(1):37\u201347. https:\/\/doi.org\/10.2310\/7750.2010.10013","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"7994_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/art.24172","volume":"61","author":"FC Wilson","year":"2009","unstructured":"Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61(2):233\u2013239. https:\/\/doi.org\/10.1002\/art.24172","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7994_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jid.2023.11.010","volume":"144","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Yi Y, Jing D, Yang S, Guo Y, Xiao H, Kuang Y, Zhu W, Zhao J, Li Y, Liu H, Li J, Chen X, Shen M (2024) Age at natural menopause, reproductive lifespan, and the risk of late-onset psoriasis and psoriatic arthritis in women: a prospective cohort study. J Invest Dermatol 144(6):1273-1281.e5. https:\/\/doi.org\/10.1016\/j.jid.2023.11.010","journal-title":"J Invest Dermatol"},{"issue":"10","key":"7994_CR48","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40266-019-00688-3","volume":"36","author":"F Caso","year":"2019","unstructured":"Caso F, Tasso M, Chimenti MS, Navarini L, Perricone C, Girolimetto N, Peluso R, Del Puente A, Afeltra A, Perricone R, Punzi L, Scarpa R, Costa L (2019) Late-onset and elderly psoriatic arthritis: clinical aspects and management. Drugs Aging 36(10):909\u2013925. https:\/\/doi.org\/10.1007\/s40266-019-00688-3","journal-title":"Drugs Aging"},{"issue":"33","key":"7994_CR49","doi-asserted-by":"publisher","first-page":"e7833","DOI":"10.1097\/MD.0000000000007833","volume":"96","author":"S Kobak","year":"2017","unstructured":"Kobak S, Yildiz F, Karaarslan A, Semiz H, Orman M (2017) Characteristics of Turkish patients with elderly onset psoriatic arthritis: a retrospective cohort study. Medicine (Baltimore) 96(33):e7833. https:\/\/doi.org\/10.1097\/MD.0000000000007833","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"7994_CR50","doi-asserted-by":"publisher","first-page":"105563","DOI":"10.1016\/j.jbspin.2023.105563","volume":"90","author":"M\u00c1 Puche-Larrubia","year":"2023","unstructured":"Puche-Larrubia M\u00c1, Ladehesa-Pineda L, L\u00f3pez-Montilla MD, Barbarroja N, Escudero-Contreras A, Vazquez-Mellado J, Collantes-Est\u00e9vez E, L\u00f3pez-Medina C (2023) Differences between early vs. late-onset of psoriatic arthritis: data from the RESPONDIA and REGISPONSER registries. Joint Bone Spine 90(4):105563. https:\/\/doi.org\/10.1016\/j.jbspin.2023.105563","journal-title":"Joint Bone Spine"},{"issue":"1","key":"7994_CR51","doi-asserted-by":"publisher","first-page":"e004062","DOI":"10.1136\/rmdopen-2023-004062","volume":"10","author":"SVJ Snoeck Henkemans","year":"2024","unstructured":"Snoeck Henkemans SVJ, de Jong PHP, Luime JJ, Kok MR, Tchetverikov I, Korswagen LA, van der Kooij SM, van Oosterhout M, Baudoin P, Bijsterbosch J, van der Kaap JH, van der Helm- Mil AHM, Vis M (2024) Window of opportunity in psoriatic arthritis: the earlier the better? RMD Open 10(1):e004062. https:\/\/doi.org\/10.1136\/rmdopen-2023-004062","journal-title":"RMD Open"},{"issue":"12","key":"7994_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210305","volume":"24","author":"G S\u00e1nchez-Rodr\u00edguez","year":"2023","unstructured":"S\u00e1nchez-Rodr\u00edguez G, Puig L (2023) Pathogenic role of IL-17 and therapeutic targeting of IL-17F in psoriatic arthritis and spondyloarthropathies. Int J Mol Sci 24(12):10305. https:\/\/doi.org\/10.3390\/ijms241210305","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07994-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07994-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07994-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:49:18Z","timestamp":1775792958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07994-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7994"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07994-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval was obtained from the Peking Union Medical College Hospital (PUMCH) Ethics Board (S-K1811). The other centers participating in CREPAR also obtained their ethical approval in accordance with local regulations. All methods were performed in accordance with the ethical standards outlined in the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}